Cargando…

How to choose a point‐of‐care testing for troponin

BACKGROUND: Point‐of‐care (POC) cTn assays are needed when the central laboratory is unable to provide timely results to the emergency department. Many POC devices are available. The prospect of choosing them is daunting. In order to provide a quick decision‐making reference for POC cTn device selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ya‐hui, Zhang, Yang, Liu, Yu‐tao, Cui, Kai, Kang, Jin‐suo, Zhou, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370753/
https://www.ncbi.nlm.nih.gov/pubmed/32222055
http://dx.doi.org/10.1002/jcla.23263
_version_ 1783561033094266880
author Lin, Ya‐hui
Zhang, Yang
Liu, Yu‐tao
Cui, Kai
Kang, Jin‐suo
Zhou, Zhou
author_facet Lin, Ya‐hui
Zhang, Yang
Liu, Yu‐tao
Cui, Kai
Kang, Jin‐suo
Zhou, Zhou
author_sort Lin, Ya‐hui
collection PubMed
description BACKGROUND: Point‐of‐care (POC) cTn assays are needed when the central laboratory is unable to provide timely results to the emergency department. Many POC devices are available. The prospect of choosing them is daunting. In order to provide a quick decision‐making reference for POC cTn device selection comparing them to the central laboratory, seven POC devices commonly employed by emergency department were evaluated. METHODS: Firstly, we reviewed all devices package inserts. Secondly, we evaluated several POC cTn assays for imprecision, linearity, and correlation with central laboratory assays according to CLSI EP protocols. The linear regression analyses were performed only for the detectable concentrations. Five cTnI devices (Alere Triage, BioMerieux Vidas, Mitsubishi Pathfast, ReLIA TZ‐301, and Radiometer AQT90) were evaluated against a contemporary cTnI assay (Beckman Access II Accu TnI). Two cTnT assays (Radiometer AQT90 and Roche Cobas h232) were compared to a high‐sensitivity (hs) cTnT method (Roche Cobas e601). RESULTS: For cTn levels around the 99th percentile upper reference limits (URLs) of the comparator assays, imprecision could not be assessed for the Alere, BioMerieux, and Cobas h232 as they gave undetectable readings due to a lack of assay sensitivity. Imprecision (CV) was unacceptably high for the ReLIA (33.3%). On account of this precision metric, these four assays were deemed unsuitable. Regression analyses showed acceptable linearity for all the POC devices. The correlation coefficients for ReLIA, BioMerieux, Cobas h232, and Radiometer cTnT were >0.95. Unlike the cTnT devices, the cTnI assays employ different capture and detection antibodies leading to non‐commutable results. The POC cTn results were concordant with their comparator—Radiometer cTnT 90%, Pathfast cTnI 85%, and Radiometer cTnI 75%. CONCLUSION: Our study provides the procedure and essential data to guide selection of a POC cTn device. Of the point‐of‐care devices, methods evaluated Radiometer AQT90 (cTnI and cTnT) and Pathfast might be considered.
format Online
Article
Text
id pubmed-7370753
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73707532020-07-21 How to choose a point‐of‐care testing for troponin Lin, Ya‐hui Zhang, Yang Liu, Yu‐tao Cui, Kai Kang, Jin‐suo Zhou, Zhou J Clin Lab Anal Research Articles BACKGROUND: Point‐of‐care (POC) cTn assays are needed when the central laboratory is unable to provide timely results to the emergency department. Many POC devices are available. The prospect of choosing them is daunting. In order to provide a quick decision‐making reference for POC cTn device selection comparing them to the central laboratory, seven POC devices commonly employed by emergency department were evaluated. METHODS: Firstly, we reviewed all devices package inserts. Secondly, we evaluated several POC cTn assays for imprecision, linearity, and correlation with central laboratory assays according to CLSI EP protocols. The linear regression analyses were performed only for the detectable concentrations. Five cTnI devices (Alere Triage, BioMerieux Vidas, Mitsubishi Pathfast, ReLIA TZ‐301, and Radiometer AQT90) were evaluated against a contemporary cTnI assay (Beckman Access II Accu TnI). Two cTnT assays (Radiometer AQT90 and Roche Cobas h232) were compared to a high‐sensitivity (hs) cTnT method (Roche Cobas e601). RESULTS: For cTn levels around the 99th percentile upper reference limits (URLs) of the comparator assays, imprecision could not be assessed for the Alere, BioMerieux, and Cobas h232 as they gave undetectable readings due to a lack of assay sensitivity. Imprecision (CV) was unacceptably high for the ReLIA (33.3%). On account of this precision metric, these four assays were deemed unsuitable. Regression analyses showed acceptable linearity for all the POC devices. The correlation coefficients for ReLIA, BioMerieux, Cobas h232, and Radiometer cTnT were >0.95. Unlike the cTnT devices, the cTnI assays employ different capture and detection antibodies leading to non‐commutable results. The POC cTn results were concordant with their comparator—Radiometer cTnT 90%, Pathfast cTnI 85%, and Radiometer cTnI 75%. CONCLUSION: Our study provides the procedure and essential data to guide selection of a POC cTn device. Of the point‐of‐care devices, methods evaluated Radiometer AQT90 (cTnI and cTnT) and Pathfast might be considered. John Wiley and Sons Inc. 2020-03-28 /pmc/articles/PMC7370753/ /pubmed/32222055 http://dx.doi.org/10.1002/jcla.23263 Text en © 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Lin, Ya‐hui
Zhang, Yang
Liu, Yu‐tao
Cui, Kai
Kang, Jin‐suo
Zhou, Zhou
How to choose a point‐of‐care testing for troponin
title How to choose a point‐of‐care testing for troponin
title_full How to choose a point‐of‐care testing for troponin
title_fullStr How to choose a point‐of‐care testing for troponin
title_full_unstemmed How to choose a point‐of‐care testing for troponin
title_short How to choose a point‐of‐care testing for troponin
title_sort how to choose a point‐of‐care testing for troponin
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370753/
https://www.ncbi.nlm.nih.gov/pubmed/32222055
http://dx.doi.org/10.1002/jcla.23263
work_keys_str_mv AT linyahui howtochooseapointofcaretestingfortroponin
AT zhangyang howtochooseapointofcaretestingfortroponin
AT liuyutao howtochooseapointofcaretestingfortroponin
AT cuikai howtochooseapointofcaretestingfortroponin
AT kangjinsuo howtochooseapointofcaretestingfortroponin
AT zhouzhou howtochooseapointofcaretestingfortroponin